InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.70
(
-0.11%
)
Bitcoin
64,967.30
(
-0.26%
)
Post# of 252255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

JJM760

Send PM Follow Ignore
Followers 5
Posts 993
Boards Moderated 0
Alias Born 06/15/2010

JJM760

Re: exwannabe post# 123818

Saturday, 07/23/2011 11:44:56 AM

Saturday, July 23, 2011 11:44:56 AM

Post# of 252255
Ex

Everyone's favorite Neop short Marty posted an opinion on SA that Lymphoseek could not be approved because the trial was run against blue dye and not the (unapproved) SOC of blue dye and SC. He even filed a silly citizen's petition based on it. Now this Pharmalucence gets approval for SC after they put it up against blue dye as well.

Regardless of one's opinion of the commercial viability and/or market share of Lymphoseek, or the valuation of Neop's pps, does this SC approval basically negate Marty's thesis?

TIA
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up